What was known before {#section11-2054358119838836}
=====================

Indigenous youth with type 2 diabetes are at very high risk of early and progressive renal complications. Traditional risk factors do not fully explain the renal morbidity seen in this population. Indigenous youth endorse mental health as important; however, its role in renal complications is unknown.

What this adds {#section12-2054358119838836}
==============

This study supports the iCARE theoretical framework, which identifies the potential multifactorial pathogenesis of early kidney injury in this population. In this preliminary analysis, glycemic control and hypertension are associated with albuminuria, while psychological stress and distress may mediate their effects on albuminuria via inflammatory pathways.

Introduction {#section13-2054358119838836}
============

Pediatric diabetes is increasing, now affecting close to 1% of children in North America.^[@bibr1-2054358119838836]^ Rates of type 2 diabetes are increasing disproportionately in minority ethnic groups such as Indigenous populations, and in some areas of the world including the Canadian province of Manitoba, new cases of type 2 diabetes now surpass new cases of type 1 diabetes. This is of significant concern because Indigenous populations have consistently been shown to be at an increased risk of chronic kidney disease (CKD) and progress more quickly throughout each stage of CKD.^[@bibr2-2054358119838836]^ Similarly, youth onset type 2 diabetes has also consistently been shown to be associated with significantly higher rates of early kidney complications, initially presenting with albuminuria as an early marker of kidney injury.^[@bibr3-2054358119838836]^ While albuminuria can regress in traditional diabetic nephropathy, it has been shown in Indigenous populations that it is less likely to do so and predicts progression to end-stage kidney disease in young adulthood.^[@bibr4-2054358119838836]^ Population-based studies have attempted to explain the excessive burden of kidney injury in youth with type 2 diabetes; however, in the absence of rigorous risk factor phenotyping and sufficient sample sizes, 80% of the increased renal burden among youth with type 2 diabetes remains unexplained.^[@bibr5-2054358119838836]^

Our group and others have documented the clinical characteristics that distinguish type 2 diabetes in youth from youth with type 1 diabetes that could explain the higher burden of kidney disease. These include greater adiposity and increased cardiometabolic risk burden.^[@bibr6-2054358119838836]^ In addition, youth with type 2 diabetes tend to live in lower socioeconomic households and are predominantly from minority ethnic groups including Indigenous communities.^[@bibr7-2054358119838836]^ Finally, compared with youth with type 1 diabetes, youth with type 2 diabetes display a low quality of life and a greater risk for depression and anxiety.^[@bibr7-2054358119838836],[@bibr8-2054358119838836]^ These factors are particularly relevant to Indigenous youth worldwide, who suffer from some of the highest rates of poor quality of life, suicide, and mental illness. To date, a comprehensive study of the impact of this clustering of interrelated risk factors on kidney injury in Indigenous youth with type 2 diabetes has yet to be performed.

The *i*mproving renal *C*omplications in *A*dolescents with type 2 diabetes through *RE*search (iCARE) cohort^[@bibr9-2054358119838836]^ was designed to evaluate the most relevant risk factors for early onset albuminuria in youth with type 2 diabetes. We have created a theoretical framework in collaboration with our patient advisory group which includes biological factors such as glycemic control and hypertension as well as psychological factors such as perceived stress and mental distress. We hypothesize that psychological pathways influence renal outcomes via metabolic hormone stimulation and subsequent influence on inflammatory pathways. Here, we present a preliminary evaluation of the planned structural equation modeling (SEM) approach.

Patients and Methods {#section14-2054358119838836}
====================

The iCARE study rationale, design, and methods have previously been reported.^[@bibr9-2054358119838836]^ In brief, iCARE is a prospective cohort study designed to discover novel risk factors and therapeutic targets for the prevention and treatment of albuminuria and progression of CKD in youth with type 2 diabetes. The study began as a single-center study in Winnipeg, Manitoba, and has now been funded to expand to a multicenter study to test a holistic bio-psycho-social (BPS) model of renal health trajectories in youth with type 2 diabetes of broader ethnic diversity with a planned sample size of 400 youth. This initial cohort was predominantly Indigenous and recruited from Manitoba and Northwestern Ontario. The study protocol was approved by the biomedical research board at the University of Manitoba, in accordance with the Declaration of Helsinki. All patients or their guardians (if less than 18 years of age) provided informed consent and youth less than 18 years provided assent. In addition, our study is guided by a patient and parent advisory group and an advisory board with representation from community and government-based organizations (First Nations Health and Social Secretariat of Manitoba, the regional CIHR-funded Partners for Engagement and Knowledge Exchange, and primary care and community-based care representatives).

Population {#section15-2054358119838836}
==========

Participants in the Manitoba iCARE cohort consist of 10- to 25-year-old adolescents and young adults diagnosed with type 2 diabetes prior to 18 years of age. The first 187 recruited in the study were included in this preliminary analysis. The diagnosis of type 2 diabetes was made according to the Canadian Diabetes Association guidelines,^[@bibr10-2054358119838836]^ consistent with those of the American Diabetes Association. The diagnosis of type 2 diabetes was based on clinical criteria including the presence of obesity, other evidence of insulin resistance, family history of type 2 diabetes, intrauterine exposure to hyperglycemia, and family heritage from a high-risk ethnic group and the absence of insulin and glutamic acid decarboxylase antibodies. Exclusion criteria were medication or surgery induced diabetes, ever being diagnosed with cancer, current treatment with immunosuppressant medications, a concomitant chronic inflammatory condition, currently being pregnant, or unable/unwilling to give consent.

Exposures and Outcome Variables {#section16-2054358119838836}
===============================

Biological Factors {#section17-2054358119838836}
------------------

To generate a continuous measure of blood pressure that was standardized to age and sex, daytime and nocturnal systolic and diastolic blood pressure loads were chosen for this initial analysis (ie, the percentage of time spent above the 95th percentile for sex and height), measured with 24-hour ambulatory blood pressure monitoring (SpaceLabs, Snoqualmie, Washington). The daytime parameter of 140/90 mm Hg and nocturnal parameter of 120/80 mm Hg were utilized for participants 18 years of age or older. Any hypertension was defined as ≥1 blood pressure parameter (daytime or nocturnal systolic or diastolic) above the 95th percentile for sex and height more than 25% of the time for youth \<18 years of age.^[@bibr11-2054358119838836]^ Glycemic control was quantified using hemoglobin A1c (HbA1c) analyzed on a Roche Cobas Integra 800 CTS (Diagnostic Services Manitoba laboratory, Health Sciences Center, Winnipeg). Smoking status was self-reported as cigarettes per day. Nonsmokers were coded as 0 cigarettes per day. Angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) use was determined from self-report.

Psychological Factors {#section18-2054358119838836}
---------------------

The following validated questionnaires were utilized to evaluate various aspects of mental health. The Kessler Psychological Distress Scale (K6) was utilized to capture symptoms of depression and anxiety. This measure has a receiver operating characteristic curve (ROC) of 0.87 to 0.88 for disorders of Global Assessment Functioning and has been used in the US Mental Health and Canadian Community Health Surveys (CCHS) for youth \>12 years of age and young adults and has been validated in many populations including Indigenous.^[@bibr12-2054358119838836]^ A score ≥13 is consistent with a mental health problem. The Perceived Stress Scale 14 (PSS-14) was used to assess perceived level of stress.^[@bibr13-2054358119838836],[@bibr14-2054358119838836]^ Higher scores reflect more perceived stress (up to 56). There are no set cutoffs. The Mental Health Continuum was used to assess positive mental health, has excellent discriminant validity in adolescents, and was also utilized in the CCHS for youth and young adults.^[@bibr15-2054358119838836]^ This scale can be scored between 0 and 70 where a higher score reflects higher levels of emotional well-being. Finally, the Resilience Scale for Children and Adolescents (RSCA), a measure specifically developed and validated in children, was used to assess the resiliency constructs of mastery, relatedness, and emotional reactivity as well as calculated resourcefulness and vulnerability scores.^[@bibr16-2054358119838836]^ We present the mean scores with standard deviation for each subscale. Higher scores reflect more resilience except for the vulnerability score which reflects more vulnerability.

Inflammatory Markers {#section19-2054358119838836}
--------------------

C-reactive protein (CRP) was quantified using a particle-enhanced immunoturbidimetric assay. Erythrocyte sedimentation rate (ESR) was quantified using Alifax Test 1 assay. Fibrinogen was assessed using the Clauss instrument coagulation instruments (from Instrumentation Laboratory). All samples were run at the Diagnostic Services Manitoba laboratory at the Health Sciences Center in Winnipeg.

Demographic Variables {#section20-2054358119838836}
---------------------

Current age, sex, self-reported ethnicity, and duration of diabetes were included as demographic variables. Height and weight were measured directly in duplicate using a calibrated stadiometer and electronic scale. The mean values were used to calculate body mass index (BMI) and BMI z-scores.

Primary Outcome {#section21-2054358119838836}
---------------

The main outcome of interest was nonorthostatic albuminuria as defined by a urine albumin to creatinine ratio (ACR) greater than 2·0 mg/mmol on an overnight urine collection (preferred), or first morning sample (if overnight sample not available). Persistent albuminuria was defined as an ACR \>2.0 mg/mmol on 2/3 samples over a 6-month period as per national guidelines.

Statistical Analysis {#section22-2054358119838836}
====================

Univariate analyses were initially conducted to inform the SEM. An SEM was chosen for this analysis as it is a powerful statistical modeling technique for observational data that can be used to statistically confirm a *hypothesized* model by evaluating the observed covariance structure of the data. It also has the ability to include latent variables, which are underlying unobservable phenomena assessed by clustering of measured indicator variables. This was especially important for our study for the inclusion of "psychological health" for example, which is not directly observable, but rather made up of a series of measurable variables like anxiety, depression, resilience, and stress, utilizing standardized tools, as described below. SEM describes a class of causal linear models representing a mix of confirmatory factor analysis (measurement model) and path analysis (structural model). Conceptually, the measurement model is first estimated and the correlation/covariance matrix used as input to estimate the structural coefficients (eg, regression betas). In practice, both models are estimated simultaneously with SEM software.

We took 2 preliminary steps to inform the final SEM. First, differences in predictor variables and confounders between groups with and without albuminuria were evaluated. *T* tests, for continuous variables, and Pearson chi-square tests, for categorical variables, were used to compare differences in exposures between youth stratified by the presence of albuminuria. A *P* value of \<.05 was considered significant for these analyses.

Subsequently, a principal component analysis (PCA) was performed. Polychoric/tetrachoric correlations were used and fitted with weighted least squares for the exploratory model without imputation. ACEi/ARB use was not included in the modeling as it is a confounder by indication.^[@bibr3-2054358119838836]^

Based on the exploratory PCA, we created a measurement model with three latent factors (hypertension, psychological wellness, and inflammation). The validity of the latent factor model was assessed by confirmatory factor analysis. Overall model fit was assessed using chi-square analysis and root mean square error approximation (RMSEA). R software 3.2 was utilized for this analysis.

*Lavaan* 0.5-18 (LAtend VAriable ANalysis; Rosseel, 2012)^[@bibr17-2054358119838836]^ was then used to fit the SEM to the study participants using diagonally weighted least squares, to accommodate 15 continuous indicators and the primary outcome, albuminuria. With item factor analysis, a continuous underlying variable was assumed to be related to albuminuria and its threshold estimated as part of the model fit. Three latent factors were included: hypertension (4 indicators = wake systolic and diastolic blood pressure loads and sleep systolic and diastolic blood pressure loads), inflammation (3 indicators = CRP, ESR, fibrinogen), and psychological wellness (indicators = distress \[K6 score\], perceived stress \[PSS-14 score\], positive mental health \[MHC score\], and resiliency measures: mastery, relatedness, reactivity, resourcefulness, and vulnerability). All latent factors were assumed to covary and each was independently allowed to causally influence albuminuria status. HbA1c and diabetes duration were treated as independent covariates with causal paths leading directly to the outcome. Model fit was assessed by chi-square, RMSEA, and comparative fit indices (Tucker--Lewis index \[TLI\]). Scale was imposed on the latent factors using the standardization method (mean = 0, SD = 1; all loadings freely estimated), and conditional local independence was assumed for all manifest variables. Missing data were imputed using multiple chained equations with 20 complete datasets. To facilitate comparison and interpretation, all parameter estimates are based on standardized variables and interpretable as correlations. The a priori theoretical model was developed by the iCARE investigators based on exploratory factor analysis, review of the literature, and input from our patient advisory group with post hoc assessment of the assumed structural form based on residual correlations and modification indices.

Results {#section23-2054358119838836}
=======

Of the 187 youth with type 2 diabetes included in this analysis, 30.5% (57/187) presented with nonorthostatic albuminuria and the majority of these cases also had persistent albuminuria (82.5%; n = 47). The median age was 15 years (IQR: 13.3-16.8), duration of type 2 diabetes was 2.3 years (IQR: 0.9-4.1), and 66.8% were female. ACEi/ARB use was identified in 24.1% of the group with albuminuria and only 3.1% of the group without it (*P* \< .001).

In the univariate analysis ([Table 1](#table1-2054358119838836){ref-type="table"}), youth with albuminuria had longer duration of diabetes (3.4 vs 2.4 years; *P* = .01), higher HbA1c (10.9% vs 8.9%; *P* \< .001), higher blood pressure loads, and were more likely to be hypertensive (94.2% vs 78.2%; *P* = .02), relative to youth without albuminuria. Age, sex, and smoking habits were not different between groups. The mental health outcomes and inflammatory markers are presented in [Table 2](#table2-2054358119838836){ref-type="table"}. Youth with albuminuria had higher distress scores (9.2 vs 7.3; *P* = .02), perceived stress scores (28.7 vs 26.4; *P* = .03), and some markers of inflammation (CRP: 4.9 vs 3.1 mg/L; *P* = .01, fibrinogen: 3.7 vs 3.3 µmol/L; *P* = .02). Positive mental health and determinants of resilience were not different between groups.

###### 

Demographic and Clinical Characteristics of the Manitoba iCARE Cohort.

![](10.1177_2054358119838836-table1)

  ----------------------------------------------------------------------------------------------------
                                                   Albuminuria group\   No albuminuria\    *P* value
                                                   N = 57 (30.5%)       N = 130 (69.5%)    
  ------------------------------------------------ -------------------- ------------------ -----------
  Age (years)                                      15.7 ± 2.4           14.9 ± 2.4         .07

  Sex (% female)                                   73.7                 63.8               .30

  Duration of diabetes (years)                     3.4 ± 2.4            2.4 ± 2.1          .01

  Indigenous ethnicity (%)                         98.2%                94.6%              .40

  BMI Z-score                                      2.4 ± 1.2            2.4 ± 1.0          .9

  HbA1c (%)\                                       10.9 ± 2.3\          8.9 ± 2.5\         \<.001
  (mmol/mol)                                       (96 ± 25.1)          (74 ± 27.3)        

  Smoking\                                         0\                   0\                 .08
  (Cigarettes per day)                             (IQR: 0-12)          (IQR: 0-13)        

  Wake systolic blood pressure load (%)            45.8\                22.9\              .003
                                                   (IQR: 10.5-94.1)     (IQR: 17.8-64.8)   

  Wake diastolic blood pressure load (%)           18.3\                10.6\              .009
                                                   (IQR: 9.8-30.4)      (IQR: 5.4-18.7)    

  Nocturnal systolic blood pressure load (%)       63.2\                47.7\              .004
                                                   (IQR: 42.0-85.9)     (IQR: 12.6-68.2)   

  Nocturnal diastolic blood pressure load (%)      63.2\                47.7\              .05
                                                   (IQR: 42-100)        (IQR: 42-85.9)     

  Any hypertension (%)                             94.2                 78.2               .02

  ACE inhibitor/angiotensin receptor blocker (%)   24.1                 3.1                \<.001
  ----------------------------------------------------------------------------------------------------

*Note.* iCARE = *i*mproving renal *C*omplications in *A*dolescents with type 2 diabetes through *RE*search; BMI = body mass index; HbA1c = hemoglobin A1c; IQR = interquartile range; ACE = angiotensin-converting enzyme.

###### 

Psychological and Inflammatory Measures of the Manitoba iCARE Cohort.

![](10.1177_2054358119838836-table2)

  ----------------------------------------------------------------------------
                            Albuminuria group\   No albuminuria\   *P* value
                            N = 57 (30.5%)       N = 130 (69.5%)   
  ------------------------- -------------------- ----------------- -----------
  Distress\                 9.2 ± 5.1            7.3 ± 4.1         .02
  (Kessler 6 score)                                                

  Perceived Stress Score\   28.7 ± 6.5           26.4 ± 5.6        .03
  (PSS-14 score)                                                   

  Positive Mental Health\   39.4 ± 17.2          44.1 ± 13.2       .08
  (MHC score)                                                      

  Mastery                   39.5 ± 10.9          40.6 ± 11.4       .6

  Relatedness               36.2 ± 12.7          39.7 ± 11.6       .1

  Reactivity                52.8 ± 12.4          52.4 ± 10.22      .8

  Resilience                36.6 ± 12.0          39.2 ± 11.8       .2

  Vulnerability             59.8 ± 11.3          58.2 ± 10.7       .4

  CRP (mg/L)                4.9\                 3.1\              .01
                            (IQR: 2.4-8.0)       (IQR: 1.7-5.5)    

  ESR (mm/h)                19.0\                14.0\             .2
                            (IQR: 8.0-30.0)      (IQR: 6.0-25.8)   

  Fibrinogen (µmol/L)       3.7 ± 0.9            3.3 ± 0.7         .02
  ----------------------------------------------------------------------------

*Note.* iCARE = *i*mproving renal *C*omplications in *A*dolescents with type 2 diabetes through *RE*search; PSS = Perceived Stress Scale; MHC = Mental Health Continuum; CRP = C-reactive protein; IQR = interquartile range; ESR = erythrocyte sedimentation rate.

The PCA identified 4 principal components, which explained 54% of the variance in the prediction of albuminuria. Based on indicators with loadings \>0.5, the latent factors were defined as psychological factors (PC1), hypertension (PC2), inflammation (PC3), and other (PC4; age and duration of diabetes). Psychological factors explained 22%, hypertension explained 12%, inflammation explained 11%, and other factors explained 9% of the variability in albuminuria (54% total variability explained) within the cohort.

The SEM is presented in [Figure 1](#fig1-2054358119838836){ref-type="fig"}. [Figure 2](#fig2-2054358119838836){ref-type="fig"} presents a revised model which includes only the statistically significant loadings. The coefficients presented in both [Table 3](#table3-2054358119838836){ref-type="table"} and [Figure 2](#fig2-2054358119838836){ref-type="fig"} can be interpreted as correlation coefficients measuring the linear relationship between the latent variable or covariate and albuminuria on a scale of −1 to 1. For example, the correlation between HbA1c and albuminuria is 0.499, whereas the correlation between hypertension and albuminuria is only 0.282. As a result, 24.9% (ie, 0.499)^[@bibr2-2054358119838836]^ of the variation in albuminuria is explained by HbA1c vs 8.0% explained by hypertension. The *P* values \<.05 suggest a statistically significant result. Overall model fit was good with a chi-square *P* value = .11 and RMSEA = 0.032 (0-0.049, *P* = .96) (ie, both *P* \> .05, therefore null hypothesis of good fit not rejected). The patient advisory group also developed a lay version of the findings which is presented as an infographic in [Figure 3](#fig3-2054358119838836){ref-type="fig"}.

![Structural equation model developed to evaluate associations between latent factors and covariates with albuminuria.\
*Note.* Variances or residual error terms not shown for clarity. CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; HbA1c = hemoglobin A1c.](10.1177_2054358119838836-fig1){#fig1-2054358119838836}

![Structural equation model showing statistically significant factor loadings.\
*Note.* Factor loadings can be interpreted as correlations. CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; HbA1c = hemoglobin A1c.](10.1177_2054358119838836-fig2){#fig2-2054358119838836}

###### 

Regression Analyses Evaluating Relationships Between Latent Factors, Covariates, and Albuminuria in the Structural Equation Model.

![](10.1177_2054358119838836-table3)

  Variables               Standardized loadings   SE     *P* value
  ----------------------- ----------------------- ------ -----------
  By albuminuria status                                  
   Hypertension           .282                    .086   .001
   Psych Factors          −.095                   .066   .148
   Inflammation           .407                    .086   \<.001
   Hemoglobin A1c         .499                    .117   \<.001
   Duration of Diabetes   .169                    .113   .136
  Covariances                                            
   Hypertension                                          
    Psych Factors         .049                    .050   .318
    Inflammation          .061                    .040   .311
   Psych Factors                                         
    Inflammation          −.198                   .040   \<.001

*Note.* Coefficients can be interpreted as correlations.

![Infographic of preliminary results from the iCARE study (designed by iCARE Participant Advisory Group (PAG)).](10.1177_2054358119838836-fig3){#fig3-2054358119838836}

[Table 3](#table3-2054358119838836){ref-type="table"} describes results from the regression analyses of the association between latent factors, covariates, and albuminuria status. Significant associations were seen with coefficients for hypertension (β = 0.28; *P* = .001), inflammation (β = 0.41; *P* \< .001), and HbA1c (β = 0.50; *P* \< .001) in the structural model for albuminuria. Psychological factors were not directly associated with albuminuria; however, there was a significant association between the psychological latent factor and inflammation (β = −0.20; *P* \< .001). This model explained 44.0% of the variance in the albuminuria status.

Discussion {#section24-2054358119838836}
==========

Indigenous youth with type 2 diabetes have a disproportionate burden of early kidney complications. In this article, we present support for a novel theoretical framework which links biological and psychological risk factors via systemic inflammatory markers with albuminuria in this population. While this analysis is preliminary, it presents the importance of a broad approach to risk evaluation in this population including gold standard measures of biological risk assessment including 24-hour ambulatory blood pressure monitoring, as well as validated mental health assessment tools.

The preliminary albuminuria rates in the iCARE cohort suggest that our cohort may be at particularly high risk. Previously reported rates of albuminuria among youth with type 2 diabetes had been quite variable. In the TODAY trial, the prevalence of albuminuria was only 6.3% among the 699 youth with type 2 diabetes at randomization and increased 2.5 fold to 16.6% over the 3.9 years of follow-up.^[@bibr18-2054358119838836]^ National surveillance studies in Canada and the United States revealed rates of albuminuria in youth with type 2 diabetes of 5.1% (Canadian Pediatric Surveillance Program)^[@bibr19-2054358119838836]^ and 22.2% (SEARCH),^[@bibr5-2054358119838836]^ respectively. Of note, albuminuria has been identified at diagnosis in many cases and therefore suggests preexisting renal injury of other causes. Importantly, all studies ensured urine samples were collected first morning or overnight to exclude nonorthostatic proteinuria. As age and duration of diabetes are similar across studies, the elevated rates of renal injury in youth within this cohort may be explained by the higher rates of metabolic decompensation (mean HbA1c = 9.9%), hypertension (\>80%), and poor mental health. It may be alarming to some readers that the glycemic control in this population is so poor. While this is an observational study, all participants are also seen clinically in the Diabetes Education Resource for Children and Adolescents (DER-CA) and receive the current education and treatment that is standard of care. The high HbA1c reflect the significant barriers that exist for these youth grounded in the past and current colonial actions that adversely affect indigenous children worldwide.^[@bibr20-2054358119838836]^ Certainly more efforts are required to identify better treatment strategies that address the existing barriers. In essence, these data reinforce calls both for tight multifactorial risk factor control and a broader, holistic approach to preventing albuminuria in Indigenous youth with type 2 diabetes.

Strict glycemic control is the current cornerstone in the prevention of complications in type 2 diabetes in adults^[@bibr21-2054358119838836]^ and youth.^[@bibr3-2054358119838836],[@bibr5-2054358119838836],[@bibr18-2054358119838836]^ While the important role of hypertension is also clear in the adult literature,^[@bibr22-2054358119838836]^ previous observational studies in children have not consistently shown hypertension to be associated with albuminuria.^[@bibr3-2054358119838836]^ The current study expands on one, relatively small (n = 24), previous report that found a positive association between hypertension, derived from using 24-hour ambulatory monitoring, and albuminuria in youth with type 2 diabetes.^[@bibr23-2054358119838836]^ Using the same methodology in a larger cohort, we found that all types of hypertension (systolic, diastolic, daytime and nocturnal) were associated with albuminuria. These factors collectively predicted \~12% of the variance in albuminuria status among youth with type 2 diabetes. This is a novel finding among youth with type 2 diabetes, as hypertension was not associated with albuminuria in either of the TODAY^[@bibr18-2054358119838836]^ or SEARCH^[@bibr5-2054358119838836]^ studies; however, importantly they did not use ambulatory monitoring to quantify blood pressure in these studies. This observation reinforces the benefits of routine utilization of 24-hour ambulatory blood pressure monitoring in youth with type 2 diabetes in clinical care. Future analyses will include the inclusion of mean blood pressure as well, which is now considered the gold standard for blood pressure assessment.

There is an increasing awareness of the potential interactions between mental and physical health among adolescents.^[@bibr24-2054358119838836]^ In the context of a chronic disease such as type 2 diabetes, psychological factors can impact quality of life^[@bibr25-2054358119838836]^ and play an important role in self-management and the adoption of healthy lifestyle behaviors.^[@bibr26-2054358119838836],[@bibr27-2054358119838836]^ Quality of life is lower^[@bibr8-2054358119838836]^ and rates of depression^[@bibr28-2054358119838836]^ are higher among youth with type 2 diabetes, relative to peers with type 1 diabetes. Indigenous youth are even more susceptible to poor mental health in part due to the combined social factors that Indigenous youth face (poverty, and racism) and the ongoing effects of multigenerational trauma.^[@bibr20-2054358119838836]^ This is the first study in Indigenous youth with type 2 diabetes to determine whether various aspects of mental health are associated with albuminuria. Although the SEM did not reveal a direct association between the cluster of mental health variables and albuminuria, the mental health latent factor was associated with elevated inflammatory biomarkers, which were themselves associated with albuminuria. Negative mental health factors can manifest in elevated stress, which activates the hypothalamic-pituitary axis and the production of cortisol.^[@bibr29-2054358119838836]^ This is a maladaptive process and can lead to systemic inflammation.^[@bibr30-2054358119838836]^ Many recent studies have identified important associations between higher levels of inflammatory cytokines and diabetes complications,^[@bibr31-2054358119838836]^ and there is also evidence that many anti-diabetic treatments have anti-inflammatory properties that are independent of their hypoglycemic effects.^[@bibr32-2054358119838836]^ Evidence is starting to emerge in adult populations that integrative care models which address biomedical, psychological, and social diabetes care lead to both improved mental health and physical health.^[@bibr33-2054358119838836]^ At this point, the impact of this type of treatment on systemic inflammation is unknown but does warrant future study. Our study does support the importance of screening for and managing poor mental health in the clinical management of Indigenous youth with type 2 diabetes.

The main strength of this study is the extensively phenotyped patient population of Indigenous youth with type 2 diabetes using gold standard methods for quantifying exposures and outcomes, including 24-hour blood pressure monitoring and overnight urine collections. We have also included validated measures of mental health to allow for inclusion of both biological and psychological determinants of risk in our analysis. The findings from the structural model revealed standardized loadings in the expected direction, and robust model fit statistics, confirming our theoretical framework. Despite these strengths, there are some limitations. First, this is a cross-sectional analysis, and therefore the associations observed cannot be considered causal. In the absence of prospective data, it is unclear whether the factors identified here will predict incident albuminuria or worsening of renal injury in youth with type 2 diabetes over time. As the iCARE cohort is a unique population, consisting largely of Indigenous youth, the generalizability of these findings in other cohorts needs to be evaluated. Finally, sample size is always an issue for complicated SEMs. Care was taken to respect the usual rule of thumb for endogenous categorical outcomes, namely 5 events (here albuminuria) for each direct parameter estimated for variables that point directly to the outcome (including slopes, variances, and covariances).^[@bibr34-2054358119838836]^

Conclusion {#section25-2054358119838836}
==========

Indigenous youth with type 2 diabetes have high rates of albuminuria. This study supports a multifactorial theoretical model linking glycemic control, hypertension, and inflammation in the pathogenesis of albuminuria in youth with type 2 diabetes. Psychological factors appear to play an important but indirect role in the pathophysiology of renal injury associated with type 2 diabetes in youth, potentially by mediating its effects through inflammatory pathways. These data support the need for more holistic models of evaluation and care for youth with type 2 diabetes and multifactorial interventions to prevent complications.
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